相关实验视频
Updated: Sep 17, 2025

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
在人类癌症中,不可逆转的非希斯顿蛋白的可逆乙化
Chunran Feng1, Yiqun Zeng1, Edward V Prochownik2
1Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
非歇斯顿蛋白的可逆乙化在癌症中至关重要. 本综述涵盖了基因组乙转移酶 (HAT) 和脱乙酶 (HDAC) 以及它们的抑制剂,用于癌症治疗.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 在过去的30年里,对非歇斯顿蛋白的可逆乙化得到了广泛的研究.
- 了解它的机制和功能后果是解读细胞过程的关键.
研究的目的:
- 审查基因组乙转移酶 (HATs) 和脱乙酶 (HDACs) 以及它们的抑制剂.
- 专注于可逆乙化在瘤发展中的作用.
- 探索HAT和HDAC抑制剂在癌症中的治疗应用.
主要方法:
- 对HATs和HDACs的文献综述.
- 分析蛋白质乙化在瘤发生中的作用.
- 在临床前和临床癌症研究中对HAT和HDAC抑制剂的评估.
主要成果:
- 在理解蛋白质乙化方面取得了重大进展.
- 可逆乙化在瘤发展的各个方面起着至关重要的作用.
- 作为癌症治疗药物,HAT和HDAC抑制剂显示出有前途.
结论:
- 可逆乙化是癌症中至关重要的调节机制.
- 针对HAT和HDAC提供了一种有前途的癌症治疗策略.
- 对HAT/HDAC抑制剂的进一步研究是有效的癌症治疗的必要条件.
相关概念视频
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Spreading of Chromatin Modifications
Writers
The writer...
Epigenetic Regulation
X-chromosome...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

